8th Annual MSK Symposium on Lymphoma — On Demand


8th Annual MSK Symposium on Lymphoma — On Demand Banner



Date & Location
Thursday, May 16, 2024, 8:00 AM - Saturday, March 1, 2025, 11:00 PM

Specialties
Specialties - Anatomic Pathology, Bone Marrow Transplant, Clinical Pathology, Geriatric Medicine, Hematology, Immunotherapy, Internal Medicine, Laboratory Medicine, Leukemia, Lymphoma, Medical Oncology, Nuclear Medicine, Oncology and Hematology, Radiation Oncology

Overview

We're pleased to offer an on demand option for the 8th edition of the MSK Symposium on Lymphoma, originally held live on April 26—27, 2024. Renowned international and national experts provide a comprehensive update on the continually evolving landscape of lymphoma research. Discover the latest breakthroughs in lymphoma biology, cutting-edge diagnostics, and groundbreaking treatment strategies that are reshaping the future of patient care. Focusing on the clinical management of the most prevalent lymphoma types, this on demand explores developments in new drugs that promise to revolutionize treatment options, as well as strategies to tailor patient care for the best outcomes.

Session topics for this on demand include:

  • DLBCL: Evolving Standards of Care and Navigating Complex Scenarios
  • Pathological Insights and Contemporary Therapeutic Breakthroughs: Keeping Pace with Recent Advances
  • Indolent NHL (1): Comprehensive Approaches to Waldenström Macroglobulinemia, Marginal Zone Lymphomas, and Mantle Cell Lymphoma
  • Optimizing Chronic Lymphocytic Leukemia Management: Harnessing New Agents for Improved Outcomes
  • Persisting Challenges and Open Questions in Primary and Secondary CNS Lymphoma
  • Strategizing the Sequence of New Therapies in Follicular Lymphoma: A Guide to Optimizing Management
  • Hodgkin Lymphoma: Enhancing Treatment Efficacy and Minimizing Side Effects

Plus, exciting new HOT TOPICS, including: 

  • Evaluating AEs and Treatment Tolerability in Clinical Trials
  • Advances in Radiomics
  • Challenges in Older Patients

Additionally, a dedicated session is included, specifically tailored for the professional development of nurses and advanced practice providers.

View the brochure from the live symposium to see a complete list of lectures available in this on demand offering.

The target audience for this program includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma.

Objectives
At the conclusion of this program, attendees will be able to:

  1. Describe recent refinements in lymphoma classification
  2. Discuss first line treatment options in the most frequent lymphoma entities
  3. Discuss options and recommendations for patients in the relapse refractory setting, including the integration of recently approved therapies
  4. Provide adequate information to help shared decision making with patients regarding their treatment

Registration

Upon successful registration, access to the course materials, including instructions for claiming credit, is located under the 'Course Content' tab. This on demand program will be available for purchase until November 30, 2024. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through February 28, 2025.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

On Demand Access Fees

  • Physicians (MDs, PhDs, and DOs): $450
  • Advanced Practice Providers: $200
  • Nurses and Other Healthcare Providers: $150
  • Residents and Fellows: $100
  • MSK Employees: Complimentary

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 12.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
  • 12.50 Lifelong Learning (CME) credits in the American Board of Pathology’s (ABPath) Continuing Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABPath MOC/CC credit.



Recorded/Review Date: April 26-April 27, 2024 | Original Release Date: May 16, 2024 | Termination Date: February 28, 2025